Tuberculous pleural effusion in Yaounde, Cameroon: The influence of HIV infection;La pleurésie tuberculeuse á Yaoundé, Cameroun : Influence de l'infection á VIH

Revue des Maladies Respiratoires

Volumn 28, Issue 9, 2011, Pages 1138-1145

  Yone, E W Pefura ^a   Kuaban, C ^a   Simo, L ^b  

^a Hopital Jamot   (Cameroon)

^b Division de la Recherche Opérationnelle en Santé   (Cameroon)

Author keywords

Adultes; Cameroun; Pl vre; Tuberculose; VIH

Indexed keywords

ADOLESCENT; ARTICLE; CAMEROON; CONTROLLED STUDY; COUGHING; FEMALE; FEVER; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG GRANULOMA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; NIGHT SWEAT; PLEURA EFFUSION; PROSPECTIVE STUDY; SPUTUM; THORAX RADIOGRAPHY; TUBERCULOUS PLEURAL EFFUSION; WEIGHT REDUCTION; CLINICAL EVALUATION; OUTCOME ASSESSMENT; TUBERCULOUS PLEURISY;

ADOLESCENT; ADULT; BACTERIOLOGICAL TECHNIQUES; BIOPSY; CAMEROON; COINFECTION; DISEASE PROGRESSION; FEMALE; HEMATOLOGIC TESTS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; TUBERCULOSIS, PLEURAL; YOUNG ADULT;

EID: 84155194638     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2011.05.008     Document Type: Article

References (30)

1. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res 2004;120:316-53. (Pubitemid 39504471)
2. Golden MP, Vikram HR. Extrapulmonary tuberculosis: An overview. Am Fam Physician 2005;72:1761-8. (Pubitemid 41633285)
3. Elliott AM, Luo N, Tembo G, et al. The impact of human immunodeficiency virus of tuberculosis in Zambia: A coss-sectionnal study. Br Med J 1990;301:412-5. (Pubitemid 20279231)
4. Heyderman RS, Makunike R, Muza T, et al. Pleural tuberculosis in Harare, Zimbabwe: The relationship between human immunodeficiency virus, CD4 lymphocyte count, granuloma formation and disseminated disease. Trop Med Int Health 1998;3:14-20. (Pubitemid 28081014)
5. Richter C, Perenboom R, Mtoni I, et al. Clinical features of HIV-seropositive and HIV-seronegative patients with tuberculous pleural effusion in Dar es Salaam, Tanzania. Chest 1994;106:1471-5.
6. Kuaban C, Gonsu FJ, Nlend R, et al. La pleurésie tuberculeuse à Yaoundé-Cameroun. J Cam Med 1992;1:7-10.
7. Kuaban C, Bercion R, Santiago M, et al. Pleurésie tuberculeuse chez les malades adultes VIH séropositifs et séronégatifs à Yaoundé (Cameroun). Sem Hop Paris 1997;73:994-9.
8. AIDS epidemic update. UNAIDS/WHO 2008, available from: URL: Http://data.unaids.org/pub/Report/2008/jc 1535 annual report07 fr.pdf. Téléchargé le 15 mai 2010.
9. Report on HIV sentinel surveillance system in Cameroon 1994. Ministry of Public Health Yaoundé, Cameroon.
10. Han DH, Song JW, Chung HS, et al. Resolution of residual pleural disease according to time course in tuberculous pleurisy during and after the termination of antituberculosis medication. Chest 2005;128:3240-5.
11. Owino EA, Mcligeyo SO, Gatthua SN, et al. Prevalence of immunodeficiency virus infection: Its impact on the diagnostic yields in exsudative pleural effusions at Kenyatta National Hospital, Nairobi. East Afr Med J 1996;73:575-8. (Pubitemid 126354397)
12. Batungwanayo J, Taelman H, Allen S, et al. Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda. AIDS 1993;7:73-9. (Pubitemid 23069035)
13. Relkin F, Aranda CP, Garay SM, et al. Pleural tuberculosis and HIV infection. Chest 1994;105:1338-41. (Pubitemid 24152583)
14. KuabanC, Bame R, Mouangue L, et al. Non conversion of sputum smear positive in new smear positive pulmonary tuberculous patients in Yaounde, Cameroon. East Afr Med J 2009;86:219-25.
15. Global tuberculosis control-epidemiology, strategy, financing. WHO Report 2009, available from: Http:// www.who.int/tb/publications/global report/2009/update/a- 1 afr.pdf. Téléchargé le 15 mai 2010.
16. Luzze H, Elliott AM, Joloba ML, et al. Evaluation of suspected tuberculous pleurisy: Clinical and diagnosis findings in HIV-1- positive and HIV-negative adults in Uganda. Int J Tuberc Lund Dis 2001;5:746-53. (Pubitemid 32720559)
17. Aderaye AG, Melaku BK, Zeneba CG. Pleural tuberculosis in patients infected with HIV in Addis Abeba. Cent Afr Med J Med 1996;42:337-40. (Pubitemid 127529655)
18. Valdés L, Alvarez D, San José E, et al. Tuberculous pleurisy: A study of 254 patients. Arch Inter Med 1998;158:2017-21. (Pubitemid 28465626)
19. Gopi A, Madhavan SM, Sharma SK. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007;131:880-9. (Pubitemid 46446885)
20. Sharma SK, Kadhiravan T, Banga A. A clinical prediction rule to identify patients with tuberculosis at high risk for HIV coinfection. Indian J Med Res 2009;1:51-7.
21. Obirikorang C, Yeboah FA. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci 2009;16:102.
22. Goletti D, Weissman D, Jackson RW, et al. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol 1996;157:1271-8.
23. Bezuidenhout J, Roberts T, Muller L, et al. Tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomas. PLoS ONE 2009;4:e4228, doi:10.1371/journal.pone.0004228.
24. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993;7:1569-79. (Pubitemid 24008849)
25. Kwon JS, Cha SI, Jeon KN, et al. Factors influencing residual pleural opacity in tuberculous pleural effusion. J Korean Med Sci 2008;23:616-20.
26. Barbas CS, Cukier A, de Varvalho CR, et al. The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. Chest 1991;100:1264-7.
27. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS 2001;15:143-52. (Pubitemid 32142288)
28. Horne DJ, Hubbard R, Narita M, et al. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis 2010;10:258.
29. Velasco M, Castilla V, Sanz J, et al. COMESEM Cohort. Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 2009;50:148-52.
30. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697-706.